ThermoGenesis Holdings Inc. (NASDAQ:THMO) traded at $0.13 at last check on Wednesday, November 23, made an upward move of 12.59% on its previous day’s price.
Looking at the stock we see that its previous close was $0.11 and the beta (5Y monthly) reads 2.23 with the day’s price range being $0.1094 – $0.116. In terms of its 52-week price range, THMO has a high of $1.89 and a low of $0.09. The company’s stock has lost about -51.33% over that past 30 days.
ThermoGenesis Holdings Inc. has a market cap of $5.44 million and is expected to release its quarterly earnings report on Nov 10, 2022. Estimates by analysts give the company expected earnings per share (EPS) of -$0.02, with the EPS growth for the year raised at -$0.32 for 2022 and -$0.03 for next year. These figures represent 66.70% and 90.60% growth in EPS for the two years respectively.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $2.89 million, with a low of $2.89 million and a high of $2.89 million. The median projection represents growth squeezing down to 19.50% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2022 is expected to hit $11.44 million, or 23.10% up from figures reported last year.
There have been 1 upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the THMO stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.
Based on estimates by 1 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 0 have rated the ThermoGenesis Holdings Inc. (THMO) stock as a Hold, while 1 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 23.33% off its SMA20 and -31.31% from its 50-day simple moving average. The RSI (14) is pointing at 45.89 while the volatility over the past week is 10.09% and jumps to 11.19% over the past one month. The beta value is 2.27, while the average true range (ATR) is currently pointing at 0.02. The average price target for the stock over the next 12 months is $1.00, with the estimates having a low of $1.00 and a high of $1.00. These price ends are -669.23% and -669.23% off the today’s price level respectively, although investors could be excited at the prospect of a -669.23% if the THMO share price touches on the median price of $1.00.
Coming back to ThermoGenesis Holdings Inc. (NASDAQ:THMO), we note that the average 3-month trading volume was 1.42 million, while that of the preceding 10-day period stands at 1.9 million. Current shares outstanding are 46.00 million.
The insiders hold 26.70% of the company’s shares while institutions hold 1.40%. The data shows that short shares as of Oct 30, 2022, stood at 0.46 million at a short ratio of 0.3. This represents a 0.99% short interest in shares outstanding on Oct 30, 2022. Shares short fall in October from the previous month at 0.76 million. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock -88.91% down in year-to-date price movement.